Jerusalem-based MonitHer makes a handheld ultrasound system that women can use regularly at home to check for abnormalities in breast tissue. The device allows women to scan their breasts once a month in approximately 10 minutes. MonitHer’s software combines artificial intelligence with the power of the cloud to detect any potential problems. It increases the chances of early detection compared to monthly self-exams and can be done more frequently than an annual mammogram.
The software is FDA-approved CADx, and MonitHer is beginning to work on a hardware prototype. In multiple studies around the U.S., the device has outperformed radiologists by 15% in differentiating between malignant and benign tumors, and significantly increases the number of lifesaving early detections.
MonitHer recently won the top award of $360,000 for its innovative device at the WeWork Creator Awards in Jerusalem.
Dr. Yehudit Abrams, a former scientist at NASA now living in Jerusalem, came up with an idea for a revolutionary new device that will allow women to test for tumors and other changes in their breast in the comfort of their own homes.
The handheld device, called MonitHer, is set to bring new hope to cancer monitoring and takes the guesswork and uncertainty out of manual self-examinations that check for abnormalities and changes in the breast. It may well put women and men on a path toward regular, safe, reliable tracking of their breast health. The technology is based on medical sonography, or ultrasound, which has been found to be better at detecting cancers in younger women under 40 years of age, and those with dense breast tissue. The handheld scanner is powered by software that combines artificial intelligence and cloud tech to take a number of breast tissue images and upload them online to be looked at by physicians. The whole process takes about 10 minutes.